Mandate

Vinge advises HealthCap in conjunction with its investment in Elsa Science

November 05, 2021 M&A

Vinge has advised HealthCap in conjunction with its investment in Elsa Science, which develops an app that provides patients suffering from rheumatoid arthritis to receive tailormade treatment.

The financing round is headed by Healthcap and also existing investors such as the Finnish venture capital company Inventure, Crowberry Capital from Iceland, Norrsken VC as well as Noaber from the Netherlands.

Vinge’s team primarily consisted of Johan WinnerbladStina BengtssonHannah Kajlinger and Lisa Hörnqvist.

Related

Vinge advises ABG Sundal Collier in connection with Conapto's issue of subsequent senior secured bonds of SEK 500 million

Vinge has advised ABG Sundal Collier as arranger in connection with Conapto Holding AB (publ)'s issue of subsequent senior secured bonds of SEK 500 million under the existing framework of SEK 2 billion.
April 24, 2026

Vinge advises GBL on its acquisition of BUKO Group

Vinge, together with Latham & Watkins, advises Groupe Bruxelles Lambert (“GBL”) (Euronext Brussels: GBLB) on its acquisition of BUKO Group, a leading platform in temporary traffic management, from funds advised by Equistone Partners Europe and the founding family, while management will re-invest alongside GBL. The transaction, which is subject to customary approvals, will entail a EUR 0.5 billion equity investment by GBL.
April 24, 2026

Vinge advise Lagercrantz Group on the business acquisition of FMK Trafikprodukter

Lagercrantz Group, through its subsidiary Nordic Road Safety, has entered into an agreement to acquire the business and assets of FMK Trafikprodukter – a niche company specialising in CE-certified road barrier systems for the Swedish and Nordic infrastructure market.
April 24, 2026